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The meeting, Bioartificial Organ II: Science, Medicine,
and Technology, sponsored by the New York Academy of
Sciences, brought together 94 participants that represented
medicine, biology, material science, and engineering to
spend 5 days debating the subject. This book, based on the
proceedings of this meeting, represents volume 875 of the
Annals of the New York Academy of Sciences. It is edited by
the conference organizers.
The book is more than 400 pages and organized in seven
parts, containing a total of 35 chapters. The first part is writ-
ten by the main editor, and it provides an overview of the risks
and requirements of bioartificial organs. Part II, “Novel
Materials,” contains chapters that review immunoisolation of
cells by semipermeable membranes and microcapsulation as
approaches to xenogeneic cells transplant. These techniques
isolate the transplanted cells and prevent access of antibodies
and complement proteins to the cells while allowing access to
oxygen and nutrients, providing the cells the necessary ingre-
dients to secrete desirable products such as hormones. In
addition, part II discusses strategies for creating biomimetic
materials designed to control cell behavior and direct organ-
specific tissue regeneration. Part III, “Encapsulation:
Fundamentals and Applications,” details various types of
encapsulation and the use of this technology for somatic gene
therapy. The remaining four parts deal with the use of this
technology in specific organ transplantation. As its title indi-
cates, part IV, “Islet Isolation, Transplantation and the
Bioartificial Pancreas,” discusses the recent scientific progress
made in islet cell isolation, preservation, transplantation, and
the application of microencapsulation in treating type I dia-
betes. Part V, “Biological Aspects,” discusses the immuno-
logic processes that impede the use of islet transplantation of
encapsulated genetically engineered cells for long-term, con-
stant delivery of peptides in diabetics. Part VI, “Bioartificial
Liver,” discusses the design and evaluation of a bioartificial
liver that would perform the functions of oxidative detoxifi-
cation, metabolism, excretion, and modulation of immune
and hormonal systems. Part VII, “Skin, Bone, Cartilage and
Craniofacial Issues,” discusses tissue engineering for craniofa-
cial bone, computer-controlled bioreactor for large-scale pro-
duction of cultured skin grafts, and tissue engineering of
cartilage by cell seeding on bioabsorbable scaffolds.
As expected from the Annals of the New York Academy of
Sciences, this volume presents the latest scientific achieve-
ments in the subject discussed. Although the subject of bioar-
tificial organs is not one that a vascular surgeon deals with
clinically, the concepts discussed are highly interesting and
indicate what is coming down the pike in the management of
diabetes, the complications of which vascular surgeons deal
with every day. The subjects discussed are important, tech-
nology driven, and quite novel. I enjoyed reading this book
and found it very interesting and stimulating.
Anton Sidawy, MD
VA Medical Center
Washington, DC
doi:10.1067/mva.2000.110402
Textbook of angiology
John Chang; New York; 2000; Springer Verlag; 1362 pages.
Dr Chang and associative editors have presented a new
text in the discipline of angiology. In the preface, they sug-
gest that a single book can no longer adequately cover every
aspect of the subject, and the intent of their text is to focus
on the important advances made during the past decade in
selected vascular disorders. With these guidelines in mind, I
will present my comments about this new text. Overall, the
quality of the writing is good and reflects the expertise of the
contributors. There is some repetition in different chapters
as might be expected from a multiauthored text.
A highlight of this text was the outstanding chapter by
Richard Fleming on the pathogenesis of vascular disease, which
included wonderful figures on the different etiologic factors.
However, this was the 64th chapter and had been preceded by
chapters 6, 34, 36, and 60 on the same subject, and they were
not nearly as comprehensive as Fleming’s chapter. The excel-
lent chapter on diabetic vascular disease (Kumal) should be the
next chapter rather than four chapters later. Improved editing
in future editions should minimize these issues.
One of my measurements of the quality of a text is the
presentation of “evidence based clinical recommendations
for therapy.” We are fortunate to have many prospective ran-
domized studies on vascular disorders: for example, stroke
reduction by carotid endarterectomy, PTA versus bypass,
lytic therapy. I believe a vascular text should present the
actual data from these different reports rather than just the
conclusions or recommendations. Such information was well
presented in the treatment of acute venous thrombosis
(Martin). But the chapters on carotid occlusive disease were
weak on the presentation of ACAS, NASCET, and the four
other randomized studies.
The chapter on the treatment of chronic lymphoedema
(Lerner) by physiotherapeutic measures was particularly
enlightening to this reviewer; the before/after photographs
were spectacular. Other outstanding chapters that warrant
mentioning are vertebral artery occlusive disease (Barkauskas),
radiocontrast agents (Quader), and preoperative cardiac test-
ing (Nozzal). The chapter on composite grafts for infrain-
guinal bypasses (Chang) proposed some configurations that I
had never even dreamed about. The chapter on venous valves
(Phifer) had excellent anatomic figures of the venous valve and
presented some animal studies on a “prosthetic venous valve,”
an area of particular interest to this reviewer.
The venous section emphasized a “European” viewpoint
for the treatment of varicose veins. The novel hypothesis that
degenerative joint disease is related to venous hypertension was
interesting but not convincing (Arnoldi). A historical anecdote
that I found interesting is presented on page 1024. This is about
the king of Troy, Philoctetes, who has a chronic leg ulcer that is
so foul that his shipmates set him ashore on the isle of Lemnos
where local physicians treated him—not very successfully—for 9
years. In the 10th year, Machaon, a most famous surgeon of the
Asclepiads, cut away the decaying flesh and applied a pressure
dressing with herbs. The leg heals, the king returns to battle and
wins. Machaon has a temple built in his honor. However, inter-
specialty jealousy was also rampant in those days, and some
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